Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Name: Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.
Creator: Linda Stein Gold
Published: 2021-08-20T15:14:32.352Z
Keywords: Clinical Trial, Scalp, Psoriasis, Quality of Life, Pruritus

Stein Gold, Linda; Papp, Kim; Pariser, David; Green, Lawrence; Bhatia, Neal; Sofen, Howard; Albrecht, Lorne; Gooderham, Melinda; Chen, Mindy; Paris, Maria; Wang, Yao; Callis Duffin, Kristina

doi:10.17632/djj5s5nyxc.2

Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Published: 20 August 2021| Version 2 | DOI: 10.17632/djj5s5nyxc.2

Contributors:

,

Description

Mendeley Supplemental Figures and Table for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Description

Files

Categories

Licence